Holen Sie sich die Stockscreener-App
2.27
4.13%
0.09
Handel nachbörslich:
2.27
Schlusskurs vom Vortag:
$2.18
Offen:
$2.19
24-Stunden-Volumen:
8,355
Relative Volume:
0.20
Marktkapitalisierung:
$3.97M
Einnahmen:
$102.80K
Nettoeinkommen (Verlust:
$-5.32M
KGV:
-0.5974
EPS:
-3.8
Netto-Cashflow:
$-5.45M
1W Leistung:
+4.61%
1M Leistung:
-0.87%
6M Leistung:
-38.06%
1J Leistung:
-48.81%
1-Tages-Spanne:
$2.18
$2.29
1-Wochen-Bereich:
$2.12
$2.50
52-Wochen-Spanne:
$1.957
$10.28
Creative Medical Technology Holdings Inc Stock (CELZ) Company Profile
Firmenname
Creative Medical Technology Holdings Inc
Sektor
Branche
Telefon
480-399-2822
Adresse
211 E. OSBORN RD., PHOENIX
Vergleichen Sie CELZ mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CELZ
Creative Medical Technology Holdings Inc
|
2.27 | 3.97M | 102.80K | -5.32M | -5.45M | -3.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.00 | 108.68B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
681.58 | 74.90B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
640.52 | 38.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
246.27 | 31.76B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
111.93 | 26.83B | 3.30B | -501.07M | 1.03B | -2.1146 |
Creative Medical Technology Holdings Inc Aktie (CELZ) Neueste Nachrichten
CELZ (Creative Medical Technology Holdings) 3-Year Revenue Growth Rate : -87.20% (As of Sep. 2024) - GuruFocus.com
Bunion correction systems Market Key Players AnalysisStryker - openPR
Creative Global Technology Holdings Ltd's Quiet Period Set To End on January 6th (NASDAQ:CGTL) - MarketBeat
Orange County Bancorp Announces Two-for-One Stock Split - Defense World
Optical Cable Corporation Releases Fourth Quarter and Fiscal Year 2024 Financial Results - Defense World
TechPrecision Corporation Announces Corporate Changes Following Annual Meeting - Defense World
Versus Systems Completes Corporate Continuance and Securities Issuance - Defense World
Creative Medical Technology Holdings, Inc. Reports Amendment to Articles of Incorporation and Voting Results Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) filed a Form 8-K with the Securities and Exchange Commission on December 19, 20 - Defense World
Mergers & Acquisitions Tracker - Plastics News
CELZ stock touches 52-week low at $2.11 amid market challenges - Investing.com India
Creative Global Technology Holdings Ltd trading resumes - Nasdaq
CELZ stock touches 52-week low at $2.21 amid market challenges - Investing.com Australia
CELZ stock touches 52-week low at $2.36 amid market challenges By Investing.com - Investing.com South Africa
CELZ stock touches 52-week low at $2.36 amid market challenges - Investing.com Canada
CELZ (Creative Medical Technology Holdings) 9-Day RSI : 39.05 (As of Nov. 28, 2024) - GuruFocus.com
Creative Global Tech opens at $4.29, IPO priced at $4 per share - Yahoo Finance
Creative Global Technology Holdings Limited Announces Closings of Its Initial Public Offering and the Underwriter’s Over-Allotment Option - Yahoo Finance
Degenerative Disc Disease Market Size in the 7MM was ~USD 3,600 Million in 2023, estimated DelveInsight - openPR
Creative Global Technology Holdings Limited Announces Pricing of Its Initial Public Offering - Yahoo Finance
CELZ (Creative Medical Technology Holdings) 3-Year FCF Grow - GuruFocus.com
CELZ (Creative Medical Technology Holdings) Cash, Cash Equi - GuruFocus.com
CELZ (Creative Medical Technology Holdings) Total Inventories : $0.00 Mil (As of Sep. 2024) - GuruFocus.com
CELZ stock touches 52-week low at $2.49 amid market challenges - Investing.com Australia
CELZ stock touches 52-week low at $2.49 amid market challenges By Investing.com - Investing.com South Africa
Can Creative Global Technology Holdings Limited's (NASDAQ:CGTL) ROE Continue To Surpass The Industry Average? - Yahoo Finance
Equities Analysts Issue Forecasts for CELZ FY2024 Earnings - Defense World
Novozymes A/S (OTCMKTS:NVZMY) & Creative Medical Technology (NASDAQ:CELZ) Head-To-Head Comparison - Defense World
Q1 Earnings Estimate for CELZ Issued By Roth Capital - Defense World
Creative Medical Technology files to sell 0.83M shares of common stocks by selling shareholders - MSN
Creative Technology (SGX:C76) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
Mesa medical manufacturer BioLab Holdings Inc. hires new COO - Daily Independent
Creative Medical Technology Holdings, Inc. Advances FDA Cleared ADAPT Clinical Trial with Positive Independent - EIN News
Creative Medical Technology Holdings, Inc. Advances FDA Cleared ADAPT Clinical Trial with Positive Independent Review, Validating the Safety and Potential of CELZ-201 for Chronic Lower Back Pain Treatment - The Manila Times
Electrify Expo Expands to New Markets in 2025 as Dallas and Chicago Join the Nation's Largest EV Festival - The Manila Times
Creative Medical passes safety review for back pain trial By Investing.com - Investing.com UK
Creative Medical Tech's CELZ-201 Back Pain Trial Advances After Positive Safety Review | CELZ Stock News - StockTitan
Creative Planning Lowers Holdings in Mirion Technologies, Inc. (NYSE:MIR) - Defense World
Weekly TechBio News: ADMET Prediction - substack.com
Creative Planning Buys New Stake in GigaCloud Technology Inc. (NASDAQ:GCT) - Defense World
Creative Medical Technology Holdings Third Quarter 2024 Earnings: US$0.75 loss per share (vs US$1.02 loss in 3Q 2023) - Yahoo Finance UK
Creative Planning Purchases 22,171 Shares of Alphatec Holdings, Inc. (NASDAQ:ATEC) - Defense World
Creative Planning Has $334,000 Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
Creative Medical Technology Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Creative Medical Technology Holdings Inc. (CELZ) Quarterly 10-Q Report - Quartzy
CELZ stock touches 52-week low at $2.65 amid market challenges - Investing.com Australia
Creative Planning Takes Position in Credo Technology Group Holding Ltd (NASDAQ:CRDO) - MarketBeat
Creative Medical Technology Holdings Inc (CELZ) Quarterly 10-Q Report - Quartz
Creative Planning Raises Holdings in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Creative Planning Increases Holdings in Universal Health Realty Income Trust (NYSE:UHT) - Defense World
Creative Planning Has $485,000 Stock Position in SS&C Technologies Holdings, Inc. (NASDAQ:SSNC) - Defense World
Creative Planning Reduces Stock Holdings in ProShares Ultra Technology (NYSEARCA:ROM) - Defense World
Finanzdaten der Creative Medical Technology Holdings Inc-Aktie (CELZ)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.65%
4.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):